Modified Trabeculectomy With an ESST Versus Conventional SST for

Status Completed

Clinical Trial Summary

- To evaluate prospectively the surgical outcome in terms of intraocular pressure control, potential advantages, disadvantages, success rate, complications and bleb morphology of this modified trabeculectomy with an extended subscleral tunnel (ESST) in comparison to the conventional subscleral trabeculectomy (SST) in management of uncontrolled primary open angle glaucoma. - This study will recruit 40 eyes of (40) candidate patients with primary open angle glaucoma (POAG) who are indicated for surgery. - The candidate patients will be recruited into 2 equal comparative groups. In group (A) 20 eyes (20 patients) who will undergo conventional (SST) with intraoperative mitomycin C (MMC) (0.03%) and group (B); 20 eyes of 20 patients will undergo trabeculectomy with an ESST also with intraoperative adjunctive MMC (0.03%).

Clinical Trial Description

- Different surgical procedures were developed and the principle behind them was to establish a fistula between the anterior chamber and the subconjunctival space to permit the aqueous humour to exit the eye. - Subscleral trabeculectomy has remained the most commonly performed glaucoma surgery to which the newer operations are compared.Although this procedure is very effective in reducing intraocular pressure (IOP) immediately, surgical failure has often been observed over time due to fibrosis of the surgical site and resultant non-filtering bleb. -Improvement of the complication profile and the efficacy of glaucoma filtering surgery is still a major concern for glaucoma surgeons.Therefore, several modifications, combinations, and new techniques of subscleral trabeculectomy have been described. - In the current study, a fornix-based conjunctival flap will be fashioned in an attempt to encourage more posterior drainage. In this modified trabeculectomy technique, an additional small perpendicular strip of sclera is removed extending from the AC to 2 mm beyond the edge of the scleral flap thus creating an extended subscleral trabeculectomy facilitating aqueous passage into the posterior subconjunctival space. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03480711
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	N/A
Start date	July 10, 2018
Completion date	March 2, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01841437` - Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry	N/A
Completed	`NCT02077231` - Study of Vitamin A and Carbomer in Comforting the Ocular Surface Irritations of Glaucoma Patients	N/A
Completed	`NCT01410188` - Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension	Phase 1/Phase 2
Recruiting	`NCT05557058` - GORE Glaucoma Drainage Implant Clinical Study	N/A
Not yet recruiting	`NCT03924544` - Decorin in Sub Scleral Trabeculectomy	Phase 1
Active, not recruiting	`NCT03673644` - Impact of Glaucoma and Visual Field Loss on Life Space
Completed	`NCT03365778` - Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment	N/A
Completed	`NCT01915940` - Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension	Phase 2
Completed	`NCT03889652` - Optical Coherence Tomography of Nerve Fiber Layer and Ganglion Cell Complex After Cataract Extraction
Terminated	`NCT03273907` - Post Approval Study of the CyPass System	N/A
Recruiting	`NCT03193333` - PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)	Phase 3
Recruiting	`NCT03921931` - Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study	N/A
Not yet recruiting	`NCT04609345` - Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients
Recruiting	`NCT05264818` - Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma
Completed	`NCT04333433` - PRESERFLO® MicroShunt Extension Study
Enrolling by invitation	`NCT02144103` - Effectiveness and Safety of Adipose-Derived Regenerative Cells for Treatment of Glaucomatous Neurodegeneration	Phase 1/Phase 2
Completed	`NCT01281020` - Adherence With Fixed Versus Unfixed Glaucoma Therapy
Recruiting	`NCT04891588` - Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD	N/A
Completed	`NCT03145129` - PAIR Study-PAP And IOP Relationship: Study 2
Completed	`NCT03104621` - Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma — POAG

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms